Long-term efficacy of TARGIT-IORT for breast cancer confirmed

The long-term results of the randomised trial testing the revolutionary procedure - TARGIT-IORT were published by the British Medical Journal on 19 August 2020


Single dose radiotherapy given during lumpectomy for breast cancer (TARGIT-IORT) was found to be as good as conventional post-operative radiotherapy for most women with early breast cancer.


In addition, TARGIT-IORT leads to fewer deaths from causes other than breast cancer, such as heart attacks, lung problems and other cancers.


A short video explains the results


Here is the press-release from University College London that explains the results

https://www.ucl.ac.uk/news/2020/aug/single-dose-radiotherapy-effective-treating-breast-cancer


The scientific summary is shown below - click on it to see the original paper on the BMJ website.

Click here to download the full paper as a PDF File

TARGIT-IORT: a quick and effective treatment for breast cancer

These results were widely reported in the media such as the lead article in the Times, London, UK, and on social networks




King Edward VII's Consulting Rooms

Prof Vaidya's Breast Clinic timings:

 

Thursdays 9.30 am to 1pm

Other days by appointment

Secretary: Shona Brogan

L: 02070348890 M: 07306 444 066

contact@londonbreastcancer.com

King Edward the VII's Hospital,

Emmanuel Kaye House
37 Devonshire St, Marylebone,

London, W1G 6QA

The London Clinic

20 Devonshire Place

London W1G 6BW